Search Results - "Morgenthaler, NG"
-
1
The use of copeptin, the stable peptide of the vasopressin precursor, in the differential diagnosis of sodium imbalance in patients with acute diseases
Published in Swiss medical weekly (2011)“…Sodium imbalance is common in-hospital electrolyte disturbance and is largely related to inequalities in water homeostasis. An important mechanism leading to…”
Get full text
Journal Article -
2
Assay for the Measurement of Copeptin, a Stable Peptide Derived from the Precursor of Vasopressin
Published in Clinical chemistry (Baltimore, Md.) (01-01-2006)“…Arginine vasopressin (AVP) is a key regulator of water balance, but its instability makes reliable measurement difficult and precludes routine use. We present…”
Get full text
Journal Article -
3
Measurement of Midregional Proadrenomedullin in Plasma with an Immunoluminometric Assay
Published in Clinical chemistry (Baltimore, Md.) (01-10-2005)“…Adrenomedullin (ADM) is a potent vasodilatory peptide, and circulating concentrations have been described for several disease states, including dysfunction of…”
Get full text
Journal Article -
4
Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients
Published in Peptides (New York, N.Y. : 1980) (01-12-2005)“…Vasopressin is one of the key regulators of the body's water and solute balance. When this balance is pathologically disturbed, determination of serum…”
Get full text
Journal Article -
5
Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma
Published in Clinical chemistry (Baltimore, Md.) (01-01-2004)Get full text
Journal Article -
6
Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study
Published in Critical care (London, England) (2005)“…Measurement of biomarkers is a potential approach to early assessment and prediction of mortality in patients with sepsis. The aim of the present study was to…”
Get full text
Journal Article -
7
Gender-specific co-activation of arginine vasopressin and the hypothalamic-pituitary-adrenal axis during stress
Published in Clinical endocrinology (Oxford) (01-04-2015)“…Summary Objective To study the interaction between copeptin and hypothalamic–pituitary–adrenal (HPA) activation in men and women during hypoglycaemic stress…”
Get full text
Journal Article -
8
Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients
Published in Peptides (New York, N.Y. : 1980) (01-08-2004)“…Adrenomedullin and PAMP are potent vasodilatory peptides derived from a common larger precursor peptide. Elevation of circulating levels of both peptides has…”
Get full text
Journal Article -
9
Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study
Published in Critical care (London, England) (01-02-2005)“…Additional biomarkers in sepsis are needed to tackle the challenges of determining prognosis and optimizing selection of high-risk patients for application of…”
Get full text
Journal Article -
10
Changes in Copeptin and Bioactive Vasopressin in Runners With and Without Hyponatremia
Published in Clinical journal of sport medicine (01-05-2011)“…OBJECTIVE:To evaluate changes in both the N-terminal (arginine vasopressin; AVP) and C-terminal (copeptin) fragments of the vasopressin prohormone before,…”
Get full text
Journal Article -
11
Midregional Pro-A-Type Natriuretic Peptide Measurements for Diagnosis of Acute Destabilized Heart Failure in Short-of-Breath Patients: Comparison with B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP
Published in Clinical chemistry (Baltimore, Md.) (01-05-2006)“…The aim of the present study was to assess the utility of amino-terminal pro-A-type natriuretic peptide (NT-proANP) measurements for the emergency diagnosis of…”
Get full text
Journal Article -
12
Copeptin, IGFBP-1, and Cardiovascular Prognosis in Patients With Type 2 Diabetes and Acute Myocardial Infarction: A report from the DIGAMI 2 trial
Published in Diabetes care (01-07-2010)“…OBJECTIVE: To determine whether C-terminal provasopressin (copeptin) explains the prognostic importance of insulin growth factor binding protein-1 (IGFBP-1) in…”
Get full text
Journal Article -
13
Delineation of the Discontinuous-Conformational Epitope of a Monoclonal Antibody Displaying Full in Vitro and in Vivo Thyrotropin Activity
Published in Molecular endocrinology (Baltimore, Md.) (01-12-2004)“…An experimental murine model of Graves’ disease was used to produce monoclonal antibodies (mAbs) with thyroid stimulating activity. Two of these, IRI-SAb2 and…”
Get full text
Journal Article -
14
Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease
Published in The journal of clinical endocrinology and metabolism (1999)“…Detection of autoantibodies to the TSH receptor (TSH-R) in Graves' disease has found widespread use in clinical routine and is performed mostly by commercial…”
Get full text
Journal Article -
15
Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptide
Published in Biological psychiatry (1969) (01-04-2005)“…Autoantibodies against amyloid beta (A beta) peptide found in patients with Alzheimer's disease (AD) also occur naturally in the general population…”
Get full text
Journal Article -
16
Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies
Published in Clinical endocrinology (Oxford) (01-11-2004)“…Summary objective Graves’ ophthalmopathy (GO) is clinically associated with autoimmune thyroid disease, and autoantibodies to thyroidal antigens, especially…”
Get full text
Journal Article -
17
200 Circulating Pro-Endothelin-1 (CT-proET-1) and Pulmonary Morbidity in Newborn Infants
Published in Archives of disease in childhood (01-10-2012)“…Background and aims Plasma concentrations of endothelin-1 (ET-1), a potent pulmonary vasoconstrictor with a short serum half-life, can be estimated by…”
Get full text
Journal Article -
18
Thyrotropin receptor autoantibodies in Graves' disease
Published in Trends in endocrinology and metabolism (01-07-2005)“…Clinical thyrotoxicosis in Graves' disease patients is caused by thyrotropin receptor (TSHR)-stimulating autoantibodies. The molecular mechanisms of TSHR…”
Get full text
Journal Article -
19
Proteolytic processing pattern of the endothelin-1 precursor in vivo
Published in Peptides (New York, N.Y. : 1980) (01-12-2005)“…Endothelin-1 (ET-1) is a potent vasoconstrictor, which has been implicated in diseases involving dysfunctions of the cardiovascular system. For the biogenesis…”
Get full text
Journal Article -
20
Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease
Published in Hormone and metabolic research (01-02-2004)“…The aim of this study was to evaluate the ability of the more sensitive second-generation TSH receptor (TRAb) assay to predict recurrent Graves' disease (GD)…”
Get more information
Journal Article